Search research articles
Contact Us
Filters
Showing results (1491-1500 of 1,553) with videos related to
Page
of 156
Sort By:
Translational Psychiatry
|
July 15, 2020
Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer's disease-type pathology and cognitive deficits in APP/PS1 mice
Jun Wang, Bin-Lu Sun, Yang Xiang, et al.
Chinese Journal of Cancer
|
December 24, 2016
Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab
Masahito Kotaka, Ruihua Xu, Kei Muro, et al.
Cancer Communications (London, England)
|
March 20, 2019
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
Feng-Hua Wang, Lin Shen, Jin Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2026
Allogeneic B7-H3-targeted CAR-Vδ1T cell therapy in advanced solid tumors: A phase I study
Chang Liu, Jiarui Li, Dan Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 16, 2023
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
Jianwei Zhang, Haibin Zhu, Lin Shen, et al.
Acta Neuropathologica
|
August 4, 2018
Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies
Jun Wang, Wang-Sheng Jin, Xian-Le Bu, et al.
Lancet (London, England)
|
August 29, 2021
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Jong-Mu Sun, Lin Shen, Manish A Shah, et al.
The Lancet. Oncology
|
May 17, 2020
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
Jing Huang, Jianming Xu, Yun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2024
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial
Yelena Y Janjigian, Jaffer A Ajani, Markus Moehler, et al.
BMJ (Clinical Research Ed.)
|
April 20, 2022
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
Zhihao Lu, Junye Wang, Yongqian Shu, et al.
Page
of 156
Search research articles
Search
Showing results (1491-1500 of 1,553) with videos related to
Sort By:
Page
of 156
Translational Psychiatry
|
July 15, 2020
Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer's disease-type pathology and cognitive deficits in APP/PS1 mice
Jun Wang, Bin-Lu Sun, Yang Xiang, et al.
Chinese Journal of Cancer
|
December 24, 2016
Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab
Masahito Kotaka, Ruihua Xu, Kei Muro, et al.
Cancer Communications (London, England)
|
March 20, 2019
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
Feng-Hua Wang, Lin Shen, Jin Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2026
Allogeneic B7-H3-targeted CAR-Vδ1T cell therapy in advanced solid tumors: A phase I study
Chang Liu, Jiarui Li, Dan Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 16, 2023
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
Jianwei Zhang, Haibin Zhu, Lin Shen, et al.
Acta Neuropathologica
|
August 4, 2018
Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies
Jun Wang, Wang-Sheng Jin, Xian-Le Bu, et al.
Lancet (London, England)
|
August 29, 2021
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Jong-Mu Sun, Lin Shen, Manish A Shah, et al.
The Lancet. Oncology
|
May 17, 2020
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
Jing Huang, Jianming Xu, Yun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2024
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial
Yelena Y Janjigian, Jaffer A Ajani, Markus Moehler, et al.
BMJ (Clinical Research Ed.)
|
April 20, 2022
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
Zhihao Lu, Junye Wang, Yongqian Shu, et al.
Page
of 156